awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36395149-45C54EEE-37DE-41B7-A100-9CF8874A0EC4
Q36395149-45C54EEE-37DE-41B7-A100-9CF8874A0EC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36395149-45C54EEE-37DE-41B7-A100-9CF8874A0EC4
Rising prostate-specific antigen after primary prostate cancer therapy.
P2860
Q36395149-45C54EEE-37DE-41B7-A100-9CF8874A0EC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36395149-45C54EEE-37DE-41B7-A100-9CF8874A0EC4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
485c21da6a4c6e09fe9834087172ae4c52c0647b
P2860
A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy.